This inventor holds 13 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Immune Targeting Systems Ltd., Altimmune UK Limited, Universitéde Strasbourg. Active years: 2006-2026.
Location History:
- Vigy, FR (2006)
- Lille, FR (2008 - 2012)
- Geispolsheim, FR (2012 - 2021)
Company Filing History:
6 out of 6 
3 out of 11 
2 out of 186 
Years Active: 2006-2026
Title: Innovations and Contributions of Inventor Dominique Bonnet
Introduction
Dominique Bonnet, an accomplished inventor based in Geispolsheim, France, has made significant contributions to the field of biomedical research. With an impressive portfolio of 11 patents, she is recognized for her innovative approaches to antigen delivery and therapeutic compounds.
Latest Patents
Bonnet’s recent patents include advancements in antigen delivery vectors and constructs. Her invention focuses on fluorocarbon vectors that facilitate the delivery of antigens to immunoresponsive target cells. This technology is pivotal in the development of vaccines and immunotherapeutics for animals. Additionally, she has made strides with her patent on pyrimidinone derivatives, which are compounds designed to neutralize the biological activity of chemokines. This innovation aims to provide effective medicaments for preventing and treating various conditions, including inflammation, autoimmune diseases, and cancer.
Career Highlights
Throughout her career, Dominique Bonnet has worked with leading organizations such as Immune Targeting Systems Ltd. and Altimmune UK Limited. Her roles at these companies have allowed her to leverage her expertise in immunology to further her research and enhance her patent portfolio.
Collaborations
Bonnet has collaborated with notable colleagues, including Philip J. Sizer and Carlton B. Brown. These partnerships have contributed to her success in developing innovative solutions that address critical biomedical challenges.
Conclusion
Dominique Bonnet stands out as a pioneering inventor whose work is poised to make a significant impact on the field of immunology. Her extensive patent portfolio and collaborations exemplify her commitment to innovation and the advancement of medical science.